Have a symptom?
See what questions
a doctor would ask.
News » New eye disease detection equipment receives FDA approval

New eye disease detection equipment receives FDA approval

RetinaPharma Technologies has received FDA approval for its product TonoPach which allows greater accuracy in the diagnosis of glaucoma and ocular hypertension. These two conditions are the leading cause of irreversible adult blindness and impaired vision. There are 7.5 million sufferers in the US of which more than 130,000 are legally blind. The product simultaneously measures corneal thickness and intraocular pressure. Having the two measures done together increases the accuracy. For example, laser vision corrective surgery and some diseases can cause thinning of the cornea which can interfere with the intraocular pressure reading and therefore cause glaucoma to be missed. Traditionally, only intraocular pressure readings were used to diagnose glaucoma or ocular hypertension but it has since been found that corneal thickness needs to be added to the equation to derive and accurate result.

Source: summary of medical news story as reported by Mysan - PR Newswire

Related Disease Topics:

Related Symptom Topics:

Article Source Details

About: New eye disease detection equipment receives FDA approval

Date: 6 January 2005

Source: Mysan - PR Newswire


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Embolization of fibroids
  • Embryonic stem cell transplant provides an alternate epilepsy therapy
  • Emergency heart attack surgery
  • Emergency room doctors need to take greater care when diagnosing patients with chest pain
  • Employee depression eats in business profits.
  • Endometrial cancer risk increased by obesity and inactivity
  • Endometriosis is often undiagnosed despite the severe symptoms it can cause
  • Enlarged prostate symptoms unknown to many men
  • Enzyme found that stops spread of cancer
  • Eosinophilic esophagitis may be misdiagnosed with GERD
  • Eosonophil presence directly linked to asthma
  • Ephedra-containing drugs banned by the FDA
  • Epilepsy patients more prone to depression

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise